Europe Kidney Cancer Drug Market Research Report Forecast 2017-2021

May 2017 | 104 pages | ID: E2063EDA6C3EN
S&P Consulting

Abstracts

The Europe Kidney Cancer Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Kidney Cancer Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Kidney Cancer Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Kidney Cancer Drug Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics

Europe Kidney Cancer Drug Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Kidney Cancer Drug Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Kidney Cancer Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Kidney Cancer Drug Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Kidney Cancer Drug (2012-2021)
  1.5.1 Europe Kidney Cancer Drug Sales and Growth Rate (2012-2021)
  1.5.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON KIDNEY CANCER DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

3.1 Kidney Cancer Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Kidney Cancer Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Kidney Cancer Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE KIDNEY CANCER DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Kidney Cancer Drug Market Competition by Manufacturers
  5.1.1 Europe Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Kidney Cancer Drug (Volume and Value) by Type
  5.2.1 Europe Kidney Cancer Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Kidney Cancer Drug (Volume and Value) by Countries
  5.3.1 Europe Kidney Cancer Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Kidney Cancer Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Kidney Cancer Drug (Volume) by Application

6 GERMANY KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Kidney Cancer Drug Sales and Value (2012-2017)
  6.1.1 Germany Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Kidney Cancer Drug Sales Price Trend (2012-2017)
6.2 Germany Kidney Cancer Drug Sales and Market Share by Manufacturers
6.3 Germany Kidney Cancer Drug Sales and Market Share by Type
6.4 Germany Kidney Cancer Drug Sales and Market Share by Application

7 FRANCE KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Kidney Cancer Drug Sales and Value (2012-2017)
  7.1.1 France Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Kidney Cancer Drug Sales Price Trend (2012-2017)
7.2 France Kidney Cancer Drug Sales and Market Share by Manufacturers
7.3 France Kidney Cancer Drug Sales and Market Share by Type
7.4 France Kidney Cancer Drug Sales and Market Share by Application

8 UK KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Kidney Cancer Drug Sales and Value (2012-2017)
  8.1.1 UK Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Kidney Cancer Drug Sales Price Trend (2012-2017)
8.2 UK Kidney Cancer Drug Sales and Market Share by Manufacturers
8.3 UK Kidney Cancer Drug Sales and Market Share by Type
8.4 UK Kidney Cancer Drug Sales and Market Share by Application

9 RUSSIA KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Kidney Cancer Drug Sales and Value (2012-2017)
  9.1.1 Russia Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Kidney Cancer Drug Sales Price Trend (2012-2017)
9.2 Russia Kidney Cancer Drug Sales and Market Share by Manufacturers
9.3 Russia Kidney Cancer Drug Sales and Market Share by Type
9.4 Russia Kidney Cancer Drug Sales and Market Share by Application

10 ITALY KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Kidney Cancer Drug Sales and Value (2012-2017)
  10.1.1 Italy Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Kidney Cancer Drug Sales Price Trend (2012-2017)
10.2 Italy Kidney Cancer Drug Sales and Market Share by Manufacturers
10.3 Italy Kidney Cancer Drug Sales and Market Share by Type
10.4 Italy Kidney Cancer Drug Sales and Market Share by Application

11 SPAIN KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Kidney Cancer Drug Sales and Value (2012-2017)
  11.1.1 Spain Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Kidney Cancer Drug Sales Price Trend (2012-2017)
11.2 Spain Kidney Cancer Drug Sales and Market Share by Manufacturers
11.3 Spain Kidney Cancer Drug Sales and Market Share by Type
11.4 Spain Kidney Cancer Drug Sales and Market Share by Application

12 BENELUX KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Kidney Cancer Drug Sales and Value (2012-2017)
  12.1.1 Benelux Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Kidney Cancer Drug Sales Price Trend (2012-2017)
12.2 Benelux Kidney Cancer Drug Sales and Market Share by Manufacturers
12.3 Benelux Kidney Cancer Drug Sales and Market Share by Type
12.4 Benelux Kidney Cancer Drug Sales and Market Share by Application

13 EUROPE KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

13.1 Bayer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 F. Hoffmann-La Roche
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 GlaxoSmithKline
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Novartis
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Pfizer
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Abbott Laboratories
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Active Biotech
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Amgen
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Argos Therapeutics
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE KIDNEY CANCER DRUG MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Kidney Cancer Drug Market Forecast by Type (2017-2021)
15.9 Europe Kidney Cancer Drug Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Type in 2015
Table Application of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Europe Kidney Cancer Drug Sales and Growth Rate (2012-2021)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Table Europe Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table Europe Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table Europe Kidney Cancer Drug Sales and Market Share by Type (2012-2017)
Table Europe Kidney Cancer Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure Europe Kidney Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Europe Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
Table Europe Kidney Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure Europe Kidney Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Kidney Cancer Drug Sales and Market Share by Countries (2012-2017)
Table Europe Kidney Cancer Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Countries (2012-2017)
Table Europe Kidney Cancer Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Kidney Cancer Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Kidney Cancer Drug by Countries (2012-2017)
Table Europe Kidney Cancer Drug Sales and Market Share by Application (2012-2017)
Table Europe Kidney Cancer Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Application (2012-2017)
Figure Germany Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Germany Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Germany Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure France Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure France Kidney Cancer Drug Sales Price Trend (2012-2017)
Table France Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Sales by Type (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table France Kidney Cancer Drug Sales by Application (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure UK Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure UK Kidney Cancer Drug Sales Price Trend (2012-2017)
Table UK Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Type (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Application (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Russia Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Russia Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Russia Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Italy Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Italy Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Italy Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Spain Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Spain Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Spain Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Benelux Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Application (2015 and 2016)
Table Bayer Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Kidney Cancer Drug Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Kidney Cancer Drug Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Kidney Cancer Drug Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Kidney Cancer Drug Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Kidney Cancer Drug Sales Market Share (2012-2017)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Active Biotech Kidney Cancer Drug Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Kidney Cancer Drug Sales Market Share (2012-2017)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Argos Therapeutics Kidney Cancer Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Germany Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure France Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure UK Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Type (2017-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
TRACON Pharmaceuticals
Wilex